Oncotarget

Vol 12, No 13

June 22, 2021

View Archive »

Order a Reprint

About The Cover

The cover for issue 13 of Oncotarget features Figure 6, "CGA analyses (expression, metastasis and prognosis) and possible CD98hc-independent cell-surface expression of LAT1 in human cells," by Hayashi, et al.

Table of Contents

News

A new class of radiosensitizers for glioblastoma

A new class of radiosensitizers for glioblastoma

https://doi.org/10.18632/oncotarget.27970

Roger Abounader,  and David Schiff
1199-1200
PDF  |  How to cite  |  Order a Reprint

Research Papers

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

https://doi.org/10.18632/oncotarget.27982

Shay Sharon, Jason R. Baird, Shelly Bambina, Gwen Kramer, Tiffany C. Blair, Shawn M. Jensen, Rom S. Leidner, R. Bryan Bell, Nardy Casap, Marka R. Crittenden,  and Michael J. Gough
1201-1213
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma

Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma

https://doi.org/10.18632/oncotarget.27992

Catherine T. Haring, Chandan Bhambhani, Collin Brummel, Brittany Jewell, Emily Bellile, Molly E. Heft Neal, Erin Sandford, Ryan M. Spengler, Apurva Bhangale, Matthew E. Spector, Jonathan McHugh, Mark E. Prince, Michelle Mierzwa, Francis P. Worden, Muneesh Tewari, Paul L. Swiecicki,  and J. Chad Brenner
1214-1229
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study

Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study

https://doi.org/10.18632/oncotarget.27991

Anjali Gupta, Taofik Oyekunle, Omolola Salako, Adetola Daramola, Olusegun Alatise, Gabriel Ogun, Adewale Adeniyi, April Deveaux, Veeral Saraiya, Allison Hall, Omobolaji Ayandipo, Thomas Olajide, Olalekan Olasehinde, Olukayode Arowolo, Adewale Adisa, Oludolapo Afuwape, Aralola Olusanya, Aderemi Adegoke, Trygve O. Tollefsbol, Donna Arnett, Michael J. Muehlbauer, Christopher B. Newgard, H3 Africa Kidney Research Network,  and Tomi Akinyemiju
1230-1242
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells

Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells

https://doi.org/10.18632/oncotarget.27989

Andrew E. Greenstein,  and Hazel J. Hunt
1243-1255
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target

Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target

https://doi.org/10.18632/oncotarget.27981

Natsumi Hayashi, Akitaka Yamasaki, Shiho Ueda, Shogo Okazaki, Yoshiya Ohno, Toshiyuki Tanaka, Yuichi Endo, Yoshihisa Tomioka, Kazue Masuko, Takashi Masuko,  and Reiko Sugiura
1256-1270
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

TERT and its binding protein: overexpression of GABPA/B in high grade gliomas

TERT and its binding protein: overexpression of GABPA/B in high grade gliomas

https://doi.org/10.18632/oncotarget.27985

Efthymios Papazacharias, Saskia Kuhl, Gabriele Röhn, Lukas Görtz, Roland Goldbrunner,  and Marco Timmer
1271-1280
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Reviews

Cross-talks in colon cancer between RAGE/AGEs axis and inflammation/immunotherapy

Cross-talks in colon cancer between RAGE/AGEs axis and inflammation/immunotherapy

https://doi.org/10.18632/oncotarget.27990

Annachiara Mollace, Maria Laura Coluccio, Giuseppe Donato, Vincenzo Mollace,  and Natalia Malara
1281-1295
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors

Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors

https://doi.org/10.18632/oncotarget.27988

Shilpa S. Dhar,  and Min Gyu Lee
1296-1308
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Research Perspectives

Targeting super-enhancers reprograms glioblastoma central carbon metabolism

Targeting super-enhancers reprograms glioblastoma central carbon metabolism

https://doi.org/10.18632/oncotarget.27938

Trang T.T. Nguyen, Mike-Andrew Westhoff, Georg Karpel-Massler,  and Markus D. Siegelin
1309-1313
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia

Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia

https://doi.org/10.18632/oncotarget.27919

Jan Philipp Bewersdorf,  and Amer M. Zeidan
1314-1317
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Editorial

The formation of pre-effectors in the steady state opens a new perspective for cancer immunosurveillance

The formation of pre-effectors in the steady state opens a new perspective for cancer immunosurveillance

https://doi.org/10.18632/oncotarget.27967

Alexey Surnov,  and Daniel Hawiger
1318-1320
PDF  |  How to cite  |  Order a Reprint

Mechanisms of gefitinib-induced interstitial pneumonitis: why and how the TKI perturbs innate immune systems?

Mechanisms of gefitinib-induced interstitial pneumonitis: why and how the TKI perturbs innate immune systems?

https://doi.org/10.18632/oncotarget.27958

Tomohiro Kagi, Takuya Noguchi,  and Atsushi Matsuzawa
1321-1322
PDF  |  How to cite  |  Order a Reprint

Corrections

Correction: BRAFV600E-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

Correction: BRAFV600E-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

https://doi.org/10.18632/oncotarget.28001

M. Herman Chui, Susanne K. Kjaer, Kirsten Frederiksen, Charlotte G. Hannibal, Tian-Li Wang, Russell Vang,  and Ie-Ming Shih
1323-1324
Correction  |  PDF  |  How to cite

Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer

Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer

https://doi.org/10.18632/oncotarget.28004

Edna Gordian, Eric A. Welsh, Nicholas Gimbrone, Erin M. Siegel, David Shibata, Ben C. Creelan, William Douglas Cress, Steven A. Eschrich, Eric B. Haura,  and Teresita Muñoz-Antonia
1325-1325
Correction  |  PDF  |  How to cite


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC